Revertants of a streptomycin-resistant, oligosporogenous mutant of Bacillus subtilis.
Revertants of a streptomycin-resistant (Strr), oligosporogenous (Spo-) mutant of Bacillus subtilis were selected form the ability to sporulate. The revertants obtained fell into two phenotypic classes: Strs Spo+ (streptomycin-sensitive, sporeforming), which arose by reversion of the streptomycin resistance mutations of the parent strain; and Strr Spo+, which arose by the acquisition of additional mutations, some of which were shown to affect ribosomal proteins. Alterations of ribosomal proteins S4 and S16 in the 30S subunit and L18 inthe 50S subunit were detected in Strr Spo+ revertants by polyacrylamide gel electrophoresis. Streptomycin resistance of the parental strain and the Strr revertants was demonstrated to reside in the 30S ribosomal subunit. The second site mutations of the revertants depressed the level of streptomycin resistance in vivo and in the in vitro translation of phage SP01 messenger ribonucleic acid (mRNA) relative to the resistance exhibited by the Strr parental strain. The Strr parent grew slowly and sporulated at approximately 1% of the wild type level. The Strr revertants closely resembled the wild type strain with regard to growth and sporulation. The Strr revertants grew at rates intermediate between those of the Strr patent and wild type, and sporulated at wild type levels.
D001412:Bacillus subtilis / Q000187:drug effects / Q000235:genetics* / Q000502:physiology; D001426:Bacterial Proteins / Q000235:genetics; D004352:Drug Resistance, Microbial; D009154:Mutation; D012269:Ribosomal Proteins / Q000235:genetics; D012270:Ribosomes / Q000187:drug effects; D013171:Spores, Bacterial; D013307:Streptomycin / Q000494:pharmacology*
D001426:Bacterial Proteins; D012269:Ribosomal Proteins; D013307:Streptomycin